Christine A. Poon
At a glance: Christine A. Poon is Director at Regeneron Pharmaceuticals (REGN). Their latest SEC Form 4, filed Nov 4, 2026, reported a sale of $211K. On file: 0 purchase lines ($0) and 12 sale lines ($11.8M).
Disclosed holdings: about $4.9M of REGN stock: 5,219 shares reported on their latest Form 4 (filed Nov 4, 2026), valued at the Nov 19, 2026 close of $932.53. This counts only REGN shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Regeneron Pharmaceuticals, Inc. (REGN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Christine A. Poon's InsiderPrint
12 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 12 times a year, typically $747K a trade; trades in the same month most years.
- Bump outward: a purchase (0)
- Dent inward: a sale (12)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Deepak NayarSvp & Gm Electronics Business · LFUS · 100% match
- Robert J. Pagano Jr.CEO, President · WTS · 100% match
- DST Managers VI Ltd10% Owner · CHYM · 100% match
- Andrew M. SapersteinPresident · MS · 100% match
- Andrew ReesCEO · CROX · 99% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 21812,831 held (−2%) | $966.74 | $211K | -3.5% |
| Nov 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 77212,059 held (−6%) | $967.38 | $747K | -3.6% |
| Nov 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 2,4999,560 held (−21%) | $968.58 | $2.4M | -3.7% |
| Nov 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 3,2036,357 held (−34%) | $969.50 | $3.1M | -3.8% |
| Nov 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 9375,420 held (−15%) | $970.51 | $909K | -3.9% |
| Nov 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 2015,219 held (−4%) | $971.31 | $195K | -4.0% |
| Oct 31SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 6508,202 held (−7%) | $652.68 | $424K | +42.9% |
| Oct 31SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 2,7355,467 held (−33%) | $653.50 | $1.8M | +42.7% |
| Oct 31SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 1,9153,552 held (−35%) | $654.42 | $1.3M | +42.5% |
| Oct 31SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 1003,452 held (−3%) | $655.10 | $66K | +42.4% |
| Oct 31SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 7122,740 held (−21%) | $656.50 | $467K | +42.0% |
| Oct 31SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 3882,352 held (−14%) | $657.29 | $255K | +41.9% |
- Sell
Director Christine A Poon sold $3.1M of REGN at $969.50 — cuts the stake by 34%.
- Sell
Director Christine A Poon sold $1.8M of REGN at $653.50 — cuts the stake by 33%.
- Sell
Director Christine A Poon sold $1.3M of REGN at $654.42 — cuts the stake by 35%.
Follow Christine A. Poon
Get one email when Christine A. Poon files a new purchase or sale. Free.
At most one email a day about Christine A. Poon, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.